London Innovation Center


UK Innovation Center

The UK has a strong history of discoveries in life sciences and is focused on fostering new models of working between universities, hospitals and businesses. The UK already has some excellent examples of networks that create a thriving life-sciences ecosystem, such as the Oxford, Cambridge and London triangle, which houses the UK’s largest biomedical cluster, with approximately 170 medical biotechnology companies linked to universities and other organizations.

Our London Innovation Center will build relationships with the academic institutions, biotech organizations and venture capital firms in the UK and will be a base for outreach throughout Europe.

Patrick Verheyen
Patrick Verheyen

Head of Johnson & Johnson Innovation Center, London

As the head of the London Innovation Center, Patrick Verheyen leads the company’s efforts to identify and catalyze early-stage innovation across Europe. Patrick has extensive expertise in assessing innovation through his experience in Mergers & Acquisitions and Business Development.

Patrick was most recently Vice President, New Ventures within Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, he led a nimble and diverse team that established strategic collaborations and identified investments that provided Janssen with access to external innovation and early product flow. The team also created a culture of out-partnering, leading to the creation of several new biotech companies.

Previously, Patrick was Vice President, Mergers & Acquisitions within the Pharmaceuticals Group. In this role, Patrick facilitated strategic collaborations and acquisitions including Crucell, Elan and Cougar Biotechnology, and established a spin-out company, Movetis, based on Janssen’s gastrointestinal pipeline portfolio. Patrick has provided expertise on most of the major M&A deals in the biotech, specialty pharmaceutical and large cap space, and assessed various risk sharing and funding arrangements with Clinical Research Organizations (CROs), private equity and government institutions.

Prior to this, Patrick held roles of increasing responsibility in Business Development within the Pharmaceuticals Group, facilitating many diverse research, license and co-promotion agreements.

Patrick joined the Johnson & Johnson Family of Companies in 1986 at Janssen Pharmaceuticals in Beerse, Belgium. He studied bio-engineering at the University of Leuven, Belgium.